Lemaitre Vascular (LMAT) Short-term Investments (2017 - 2026)

Lemaitre Vascular (LMAT) has 10 years of Short-term Investments data on file, last reported at $340.4 million in Q1 2026.

• On a quarterly basis, Short-term Investments rose 22.79% year-over-year to $340.4 million in Q1 2026; TTM through Mar 2026 was $340.4 million, a 22.79% increase from a year earlier, with the FY2025 full-year figure at $330.9 million, up 20.71% from the prior year.
• Short-term Investments for Q1 2026 stood at $340.4 million, up from $330.9 million in the prior quarter.
• Over the last five years, Short-term Investments for LMAT reached as high as $340.4 million in Q1 2026 and fell as low as $54.9 million in Q2 2022.
• Historically, Short-term Investments has averaged $155.3 million across 5 years, with a median of $81.7 million in 2024.
• On a YoY basis, Short-term Investments climbed as much as 25751.4% in 2022 and fell as far as 13.28% in 2022.
• Year by year, Short-term Investments stood at $63.6 million in 2022, then grew by 27.14% to $80.8 million in 2023, then surged by 239.23% to $274.1 million in 2024, then climbed by 20.71% to $330.9 million in 2025, then grew by 2.87% to $340.4 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $340.4 million in Q1 2026, $330.9 million in Q4 2025, and $317.6 million in Q3 2025.